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Abstract
Background: Genomic analysis will greatly benefit from considering in a global way various
sources of molecular data with the related biological knowledge. It is thus of great importance to
provide useful integrative approaches dedicated to ease the interpretation of microarray data.
Results: Here, we introduce a data-mining approach, Multiple Factor Analysis (MFA), to combine
multiple data sets and to add formalized knowledge. MFA is used to jointly analyse the structure
emerging from genomic and transcriptomic data sets. The common structures are underlined and
graphical outputs are provided such that biological meaning becomes easily retrievable. Gene
Ontology terms are used to build gene modules that are superimposed on the experimentally
interpreted plots. Functional interpretations are then supported by a step-by-step sequence of
graphical representations.
Conclusion: When applied to genomic and transcriptomic data and associated Gene Ontology
annotations, our method prioritize the biological processes linked to the experimental settings.
Furthermore, it reduces the time and effort to analyze large amounts of 'Omics' data.
Background
Genome-wide analyses provide an unprecedented
amount of data leading to new interpretation challenges.
Classical microarrays can monitor the expression of
potentially all genes within a cell or a tissue sample. More
recently, new applications have been developed. They
include chromatin-immunoprecipitation-chip (ChIP-on-
Chip), analysis of alternative splicing (Exon array), char-
acterization of the methylome, polymorphism genotyp-
ing (SNP array), copy-number measurements (CGH
array) and genome resequencing (for review [1,2]). A
great interest in the statistical analysis of these 'Omics'
data has emerged and many methodologies have been
developed. However, if the inferential statistics analyses
are now guided by consensual methods [3,4], the descrip-
tive analysis is often succinct if not neglected. Two reasons
can be advanced: (i) the great volume of information
makes difficult the interpretation of the results, and (ii)
heterogeneous data and multiple sources of information
are difficult to integrate in a global analysis. Methods that
overcome these difficulties are necessary as the under-
standing of a biological phenomenon would greatly ben-
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efit from considering simultaneously several types of
'Omics' data and particularly with biological knowledge.
This could be done in a multidimensional exploratory
approach.
In a multidimensional exploratory approach, a microar-
ray data set is usually analyzed by multivariate analysis
(MVA) among which Principal Components Analysis
(PCA) is the most used. PCA is well adapted to the frame-
work of 'Omics' data as it can handle data sets with much
more variables (genes) than samples (arrays). To analyze
simultaneously several data sets, the proper way is to use
MVA's dedicated to the analysis of multi-way data tables;
the method of reference being the generalized canonical
analysis (GCA) [5]. In the field of microarray, GCA is
however limited by the problem of multi-colinearity. To
bypass this limitation, only two alternatives have still
been proposed: the generalized co-inertia analysis (CIA)
[6-8] and the recently applied regularized canonical corre-
lation analysis (RCCA) [9,10].
The need for integrating external information in MVA to
ease the interpretation of microarray data have also been
pointed out. As proposed by Busold et al. [11], Fagan et al.
[12] superimposed Gene Ontology (GO) terms as supple-
mentary elements onto CIA projections. In this study, GO
terms are formalized as boolean vectors that are projected
onto CIA plots after matrix transformations. Although
CIA approach provide good results in combining molecu-
lar data sets, the way GO terms are added is not straight-
forward and appears incomplete. Indeed, this method
codes the links between genes and GO terms and do not
take into account the microarray values or molecular data
of the genes related to each GO term. Other computa-
tional methods, such as gene set enrichment analysis
(GSEA) [13], have shown the importance of focusing on
groups of genes as opposed to individual genes for incor-
porating biological information and gene sets into micro-
array data analysis. Following this philosophy, a proper
integration of biological information in MVA will gain in
accuracy by grouping genes into knowledge-related mod-
ules, and thus by considering a 'modular approach'
[14,15]. Such an approach studies as a whole the behavior
and structure of a biological process in addition to analyz-
ing its components (genes and/or gene products) individ-
ually.
In this article, we suggest to use Multiple Factor Analysis
(MFA) in the sense of Escofier-Pagès [16,17] to integrate
bio-molecular data sets as well as informations on the
genes structured in modules. MFA is dedicated to the
simultaneous exploration of multi-way data sets where
the same individuals are described by several groups of
variables. MFA is commonly applied to sensory and ecol-
ogy data and it has already been applied to the analysis of
metabonomic data [18]. MFA can be related to GCA and
CIA since it could be considered as a particular general-
ized canonical analysis were the inertia criteria replaces
the correlation criteria. These methods display a low-
dimensional projection of the data highlighting the main
sources of variability. Results should therefore be inter-
preted with caution as sources of variability are not always
due to specific biological factors of interest. It is also
important to note that at the sample level, the structures
provided either by MFA or CIA are highly similar [6]. The
assets of MFA appear when integrating both numerical
and categorical groups of variables, and when supplemen-
tary groups of data need to be added in the analysis. Here,
we present our approach by introducing the basis of MFA
and we state how MFA is particularly well adapted to inte-
grate formalized biological knowledge. We illustrate our
method with a glioma study [19,20] performed with both
CGH array and expression microarray on the same tumor
samples. Results shows that both DNA copy number alter-
ation and transcriptome data sets induce a good separa-
tion of the gliomas according to the WHO classification.
The superimposition of the gene modules built since GO
annotation identify regulatory mechanisms implicated in
gliomagenesis. We also show that our approach can han-
dle a single data set with associated GO annotations and
therefore be used as an exploratory tool in the case of clas-
sical single 'Omics' study. Finally we present another illus-
tration focused on a nutrition study in mice and
integrating microarray and lipidomic data.
Results and discussion
MFA is used to analyze several groups of 'Omics' variables
(numerical and/or categorical) defined on the same sam-
ples. The core of MFA is a PCA applied to the whole set of
variables in which each group of variables is weighted,
rendering possible the analysis of different points of view
by taking them equally into account. To illustrate the
main features of our approach a schematic is provided in
Figure 1. Each time, MFA is applied to published-data
selections (see the section Data and notations in the Mate-
rials and Methods). Resulting graphical outputs for the first
two principal components (PC1 and PC2) are used. We
describe the results and discuss the following points:
(i) the combination of paired CGH array and microarray
data of glial tumors;
(ii) the assemblage of genes into modules based on Gene
Ontology terms and their superimposition on the princi-
pal components issued of point (i), supporting interpreta-
tion of the study;
(iii) the application of our approach in the case of a single
'Omics' study (transcriptome of gliomas);BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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Schematic of our MFA based approach to combine 'Omics' data and to integrate biological Knowledge Figure 1
Schematic of our MFA based approach to combine 'Omics' data and to integrate biological Knowledge. (I) The 
heart of MFA is a PCA in which weights are assigned to the variables: (i) When several sets of variables describe a same set of 
individuals (tumors), it is possible to consider the merged data set: K = [K1, K2,..., KJ], where each Kj corresponds to an 'Omics' 
data table. (ii) Separate analysis are performed by principal components analysis (PCA) on each group j of variables. Each varia-
ble belonging to a group j is weighted by 1/ , where   denotes the first eigenvalue of the matrix of variance-covariance 
associated with each data table Kj. (iii) A global analysis is performed. The corresponding graphical displays (Individual Factor 
Map and Variables Representation) are read as for PCA. (II) MFA allows to look for common factors by providing a represen-
tation of each matrix of variables (Groups Representation). It provides the visualization of specific and common structure 
emerging from the Kj. MFA allows to compare the main factors of variability by linking both groups and variables representa-
tions. As the coordinates of set j upon axis of rank s is equal to Lg(zs, Kj): set coordinates are always comprised between 0 and 
1; and a small distance between two set along axis s means that they include the structure expressed by factor s each one with 
the same intensity. (III) The asset of MFA to add supplementary groups of variables is used to integrate biological knowledge. 
The BP modules are formalized as   matrices containing the restriction of the whole data set to the genes associated with 
the ith BP. The projection of the   is made by means of its scalar product matrix between individuals. This matrix denoted 
Wi is a a (I × I) matrix (Wi =  ) and can be considered as an element of the space  . This element is thus projected 
on the dimensions of   issued from MFA. This representation of the groups is made available by means of a graphical display 
of the   as points in a scatter plot. It has to be read as follow: the coordinate of a given group is all the more close to 1 
than the variables of this group are highly correlated with the dimension issued from the MFA (either positively or negatively). 
Hence, two groups are all the more close than the structures they induce on the observations are close.
l1
i l1
i
K BPi
K BPi
KK BP BP ii ′ R
I
2
R
I
2
K BPiBMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
Page 4 of 17
(page number not for citation purposes)
(iv) an other illustration of our method with a different
experimental setting using a nutrition study including
microarrays and fatty acids gas chromatography data.
The analyses have been performed with R and the package
FactoMineR [21].
Multi-way glioma data set
Joining 'Omics' distinct points of view (genome and transcriptome)
MFA is applied to the paired CGH array and microarray
glioma data of Bredel et al. [19,20]. The resulting sample
plots (33.7% of the total variability) are presented Figure
2 and Figure 3. The mean representation of the samples
according to both CGH and gene expression data sets is
presented Figure 2. Mean samples are represented by
points colored following WHO classification of the
tumors. Figure 3A shows the partial representation associ-
ated to each type of tumors (WHO classification: O, oli-
godendrogliomas; A, astrocytomas; OA, mixed oligo-
astrocytomas and GBM, glioblastomas). This representa-
tion is obtained from the consensus between the CGH
and expression (eX) points of view (i.e. genome and tran-
scriptome variations). Each type of tumors is represented
by three points: the consensus between the two points of
view and a point for each point of view. Both scatter plots
show a well-defined partition of the samples into WHO
classification. This is particularly true along PC1 that
underlines a partition of the samples into glioblastomas
(GBM) and lower grade gliomas (O, A, OA). Partial repre-
sentation (Figure 3A) and groups representation (Figure
3B) show that this partition exists (i) on PC1 at the
genome and at the transcriptome levels and (ii) only at
the genome level on PC2. Indeed, the projections on PC1
of the partial points for each category of tumors (CGH
and eX for O, A, OA and GBM) are each time very close,
meaning that CGH and eX define similar structures upon
tumors on PC1. In a same manner, the projections of
groups CGH and eX on PC1 have coordinates close to 1.
On PC2, all the mean individuals from the partial expres-
sion representation (eX) are located around the origin,
which is not the case for the genomic one (CGH); mean-
ing that PC2 is specific to the genomic point of view. In
the same manner, only projection of group CGH on PC2
has coordinates close to 1 (Figure 3B). Regarding CGH
data, PC2 provides a partition of the histological subtypes
and particularly stresses differences between oligodendro-
gliomas (O) and astrocytomas (A). The one-variable
group WHO summarizing the tumor classification is pro-
jected as an illustrative group (Figure 3B). Since its coordi-
nate on PC1 is rather high, the structure induced by this
group is linked to PC1: the types of tumors are well sepa-
rated along this dimension. Its coordinate on PC2 is also
relatively important, showing that the types of tumors are
also separated on PC2. Following the examination of
these graphical outputs, PC1 is linked to glioblastoma char-
acteristics and PC2 corresponds to oligodendroglioma char-
acteristics  as it stresses the differences between these
tumors and the other gliomas.
Beyond the partition of the tumors, the challenge lies in
interpreting the results to gain insights into biological
mechanisms. The classical way is to identify the genes
most correlated with each principal component, see Vari-
ables Representation (Figure 4). This scatter plot repre-
senting the genes is read as in PCA. Briefly, the genes are
projected on the factor map and represented as vectors.
The more a vector has a magnitude close to 1, the best the
projection is. The vector points in the direction of the high
values, e.g. in our case, a gene with a corresponding vector
pointing in the right side takes higest values in oligoden-
drogliomas compared to glioblastomas. We thus retrieved
the genes most correlated with PC1 and PC2. Once the
identifiers recovered, they can be annotated manually by
gathering functional information from a large panel of
databases and annotation tools. For example, the manual
examination of the genes linked to PC2 underlines
genomic status modifications of genes located on 1p and
19q positions (Table 1). Allelic alterations of chromo-
somes 1 (short arm) and 19 (long arm) are frequently
reported as important events in gliomas [22] and espe-
cially in oligodendrogliomas [23]. Indeed, it is reported
that these chromosomal aberrations patterns vary accord-
ing to the categories of glial neoplasms and could be
marks of malignant progression [24]. This process is how-
ever laborious and highly time consuming. Moreover, the
interpretation of such emphasized structures remains dif-
ficult when only associated gene IDs are accessible or
when lots of genes have to be taken into account. For that
reason, providing gene annotations in a corresponding
plot is necessary to obtain a concise way of understanding
these results.
Integrating biological knowledge: superimposition of GO gene 
modules
As we pointed out, the interpretation of the structures
emerging from MFA constitute a difficult and time-con-
suming step. Our approach aims at easing this task.
Firstly, the biological knowledge is formalized. Here,
Gene Ontology (GO) biological process (BP) terms are
used to assemble gene modules. Secondly, the gene mod-
ules are superimposed on the same principal components
and aid interpretation of the study. This is allowed by the
capacity of MFA to integrate supplementary groups of
data. The results has to be read as follow: the coordinate
of a given group is all the more close to 1 than the varia-
bles of this group are highly correlated with the dimen-
sion issued from the MFA. Hence, two groups are all the
more close than the structures they induce on the observa-
tions are close. Thus, the coordinate of one gene module
provides a direct measure of the link between its constitut-BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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Multi-way glioma data set: MFA consensus between CGH and expression highlights a partition of gliomas into WHO classifica- tion Figure 2
Multi-way glioma data set: MFA consensus between CGH and expression highlights a partition of gliomas into 
WHO classification. Individuals (tumors) are presented as points on the scatter plot created with the first two main dimen-
sions of MFA. Each individual is colored following the glioma subtype (WHO classification); mean individual are also displayed. 
Projection of the tumors onto PC1 underlines a partition into glioblastomas (GBM) and lower grade gliomas (oligodendroglio-
mas, astrocytomas, oligoastrocytomas). PC2 mainly stresses differences between astrocytomas (A) and oligodendrogliomas 
(O). As PC1 and PC2 represents the first two main factors of MFA they could be interpretated: PC1 summarizes characteristics 
of glioblastoma i.e. transcriptional differences existing between glioblastomas and lower grade gliomas; PC2 summarizes charac-
teristics of oligodendrogliomas as it stresses the differences between glial tumors coming from astrocytic cells from those arising 
from oligodendroglial ones.BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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ing genes and the corresponding principal component
(glioblastoma characteristics for PC1 and oligodendroglioma
characteristics for PC2).
Figure 5 provides a typology of the modules and high-
lights shared dimensions between GO BP terms and
tumor groups. To facilitate the interpretation of the plot,
the GO terms with highest coordinates (> 0.85 for PC1
and > 0.5 for PC2) are listed on separated boxes (blue for
PC1 and grey for PC2). PC1 or glioblastoma characteristics
is thus interpreted thanks to its BP-associated list. As
example, three main BP categories are particularly repre-
sented. The first one supports the proliferative behavior of
GBM cells (red arrows) with GO terms like 'localization of
cell' (GO:0051674), 'cell proliferation' (GO: 0008283),
and 'regulation of cell proliferation' (GO:0008284). The
second one is related to the cell cycle (black arrows) with
'positive regulation of apoptosis' (GO:0043065),
'death'(GO:0016265), and 'mitotic cell cycle'
(GO:0000278). Eventually, a third one indicates a link
with the response to a stimulus, particularly stress and
defense (green arrows): 'defense response'
(GO:0006952), 'response to wounding' (GO:0009611),
and 'wound healing' (GO:0042060). These annotations
underline the hallmark of glioblastomas: a rapid progres-
sion with cell cycle dysfunctions, important angiogenesis
and highly proliferative and invasive tumor cells. The fac-
tor delineating oligendroglial tumors from the other glio-
mas (PC2) is mainly associated with modules related to
transport and to transcription processes. Among these
biological processes, 'protein metabolism'
(GO:0019538), 'transport' (GO:0006810), and 'transcrip-
tion DNA-dependent' (GO:0006350) annotate 18 genes
of those located on 1p or 19q. The homogeneity and
coherence of these modules associated with targeted dam-
ages of the genome structure appear as potential cumula-
tive events. They appear to be distinctive features of
oligendroglioma and could therefore constitute reliable
markers for glioma diagnostic.
Multi-way glioma data set: Characteristics of glioblastoma are linked to CGH and expression data whereas characteristics of  oligodendrogliomas are mostly related to CGH data Figure 3
Multi-way glioma data set: Characteristics of glioblastoma are linked to CGH and expression data whereas 
characteristics of oligodendrogliomas are mostly related to CGH data. The partial representation of the mean indi-
viduals (CGH and eX) for each WHO tumor type (A) and the group representation (B) are displayed. (A) The balanced repre-
sentation of each category is located in the exact barycenter of the points summarizing partial points of view (CGH; linked by 
plain line and eX; linked by dot line). The projection of the partial representations for each category (CGH and eX for oli-
godendrogliomas, astrocytomas, oligoastrocytomas and glioblastomas) onto PC1 are very close; the partition of the tumors 
into WHO classification is thus shared by the genome and the transcriptome. On PC2, all the mean individuals from the partial 
expression representation (eX) are located around the origin. It is not the case for the genomic one (CGH). PC2 is therefore 
specific to the genomic point of view and is not shared by the expressional one. This is confirmed by analyzing the group rep-
resentation (B): projection of the CGH and eX groups are closed along PC1 but only the one of CGH have a value close to 1 
on PC2.BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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Single glioma data set
We used the same approach to analyze the transcriptome
data from Freije et al.. To achieve this, we applied MFA to
the duplicated data set. Performing such task is strictly
equivalent to applying a PCA on the initial data set. The
results provided correspond to those obtained with a PCA
and it becomes possible to manage additional informa-
tive groups of variables. To analyze the results, we follow
a step-by-step interpretation of the principal components:
based firstly on the typology of the tumors, secondly on
the gene expression signatures and then, on the associated
biological knowledge.
We focus on the first two principal components that
explain 47.1% of the total variability carried by the 615
genes. The corresponding individuals factor map is pro-
vided in Figure 6. Mean observations are added for each
glioma subtype to help with the interpretation of the plot.
This map shows a relatively well-defined partition of
tumors into WHO classification. It also shows that the
position of the samples belonging to a glioma subtype
varies from one to another. This variability could be
assigned to the well known cellular heterogeneity of glio-
mas and particularly of glioblastomas. It could also be the
result of the WHO classification that is somehow contro-
versial: this standard classification is said to suffer from a
lack of reproducibility among pathologists [25]. The pro-
jections on PC1 of the mean observations underline that
the maximum of variability captured in the analysis sepa-
rates glioblastomas (GBM) from lower grade gliomas (O,
A, OA). PC2 differentiates oligo-astrocytomas (OA) from
the other subtypes (O, A, GBM). As a result, PC1 is linked
to glioblastoma characteristics stating transcriptional differ-
ences between grade IV and lower grade gliomas and PC2
is related to oligoastrocytoma characteristics, highlighting
OA particular signature.
To assign a meaning, based on gene expression, to the
glioblastoma characteristics, we retrieved the ten genes most
strongly correlated with the first axis (Table 2). These
genes were manually annotated by gathering some infor-
mation from PubMed and were analyzed using the Inge-
nuity Pathway Analysis (IPA, Mountain View, CA).
Among these ten genes, four are co-cited with 'glioma' on
PubMed and five with 'cancer'. And the IPA analyses gives
links between ANXA2, CLIC1, HEXB, MAPT and S100A11
in a network related to 'Cellular Movement, Cell-To-Cell
Signaling and Interaction, Nervous System Development
and Function'. These findings are in adequacy with the
invasive nature of glioblastoma compare to lower grade
glioma i.e. with glioblastoma characteristics. However, this
interpretation step is partial as it was limited to only few
genes; it thus will gain by integrating a global view of the
associated knowledge.
We superimpose the associated biological knowledge as
GO modules on the previously analyzed plots. The corre-
sponding map (Figure 7) provides a typology of the func-
tional modules and highlights shared dimensions
between GO BP terms and tumor groups. As seen before,
the coordinates of the annotation groups onto each prin-
cipal component provide a direct measure of the links
between modules and the corresponding factors (i.e.,
glioblastoma characteristics for PC1 and oligoastrocytoma
characteristics for PC2). We focus on the gene modules
linked to the glioblastomas and retrieved 49 direct GO
terms strongly associated with grading (PC1: coordinate ≥
0.9). Among them, 27 GO terms were picked as they can
be grouped into three main biological process categories
(Table 3). The first main category is related to cell death
and cell cycle regulation and the second one stresses that
glioblastoma have a particular proliferative behavior. The
third one indicates a link with developmental functions,
more precisely in brain. These groups of annotations
underline the well known characteristics of glioblastomas
among other gliomas: a rapid cellular proliferation sus-
tained by cell cycle dysfunctions and invasion of the
parenchyma by isolated tumor cells. Moreover, our
approach emphasizes the existence of a relation from neu-
rogenesis-related genes to glioma grades of malignity. This
supports the evidence that glioblastomas contain and may
arise from neural stem cells or from differentiated cell
types that display multipotential stem cell-like properties.
The factor delineating the oligo-astrocytic tumors from
the other ones (PC2) is particularly associated with mod-
ules related to the cytoskeleton. It is thus possible to high-
Table 1: Multi-way data set: Genes strongly correlating with 
characteristics of oligodendrogliomas.
Gene Symbol Chromosome
ZNF233 19q13.31
APOC1 19q13.2
ZNF329 19q13.43
DCLRE1B 1p11.1
LILRA1 19q13.4
EDG1 1p21
ZNF226 19q13.2
GPSM2 1p13.3
ZNF549 19q13.43
KIAA1543 19p13.3-p13.2
IGSF3 1p13
BCAM 19q12-q13
ISOC2 19q13.42
EGLN2 19q13
CEAL1 19q13.31
The first 15 genes most strongly correlating with PC2 are shown with 
identifiers and corresponding chromosome locations. PC2 stresses 
differences between oligodendrogliomas (O) and other gliomas and is 
linked to the modifications of the genomic status of genes located on 
1p and 19q. This highlights that oligodendrogliomas could be 
associated with a specific allelic alterations of chromosomes 1 (short 
arm) and 19 (long arm).BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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light 'cytoskeleton-dependent intracellular transport'
(GO:0030705), 'cortical actin cytoskeleton organization
and biogenesis' (GO:0030866) and 'positive regulation of
nucleocytoplasmic transport' (GO:0046824). These bio-
logical processes stress that the main dissimilarity existing
between OA and other gliomas may emerge from a tran-
scriptional modification of genes linked to actin cytoskel-
eton which is one of the possible determinants of human
astrocytoma migration [26]. Seven genes are annotated
with these GO BP terms: DYNC1H1, EPB41L2, KIF3A,
KIF5B, MYL6, MYO9B, TRIP6. Among them, some are
reported to be involved in cancer cell migration. Specifi-
Multi-way glioma data set: Characteristics of oligodendrogliomas are linked to modifications of the genomic status of genes  located on 1p and 19q positions Figure 4
Multi-way glioma data set: Characteristics of oligodendrogliomas are linked to modifications of the genomic 
status of genes located on 1p and 19q positions. The Variables Representation is displayed and the genes that are the 
most correlated to each principal components (ten positively and ten negatively) are named. Each genes of the two groups 
(CGH, red and eX, green) are projected on the factor map and represented as a vector. This scatter plot is read as in PCA. 
The more a vector has a magnitude close to 1, the best the projection is. The vector points in the direction of the high values, 
e.g. in our case, a gene from eX corresponding to a vector pointing in the right side is over expressed in oligodendroglioma 
compared to glioblastoma. The examination of the genes linked to PC2 underlines modifications of the genomic status of genes 
located on 1p and 19q positions (see Table 1).BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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cally, cytoskeleton rearrangements have been shown to be
induced by a down-regulation of TRIP6 in carcinoma cell
lines [27]. It was also suggested that MYL6 could have an
effect on the migration of breast cancer cells [28]. Thus,
the gene EPB41L2 codes a protein belonging to the pro-
tein 4.1 family which is proposed to have roles in human
cancer [29]. And an increased expression of KIF3A may
also be associated with Autocrine motility factor-induced
signaling for cell motility and metastasis [30]. To our
knowledge, none of these genes have been so far shown to
be involved in glioma invasiveness.
Multi-way nutrimouse data set
In this section we describe another scenario with control-
led experimental design where biological units (mice) are
cross-classified according to two factors: Genotype (wild-
type (WT) versus PPAR  deficient mice (PPAR)) and Diet
(5 diets with different fatty acid (FA) compositions). The
measurements come from two different sources of infor-
mation: transcriptome variables and hepatic FA measure-
ments. With this example, we wish to illustrate the
relevance of MFA-based interpretations in accordance
with the conclusions drawn by specialists in [31].
Multi-way glioma data set: Superimposing biological knowledge underline hallmark of glioblastomas and potential markers for  glioma diagnostic Figure 5
Multi-way glioma data set: Superimposing biological knowledge underline hallmark of glioblastomas and 
potential markers for glioma diagnostic. Each group of variables is projected on the factor map created by MFA: active 
groups (points) and gene modules (triangles) are plotted. Only GO identifiers representing modules highly linked to the dimen-
sions 1 and 2 are displayed. To facilitate the interpretation of the plot, only GO terms representing modules highly linked to 
PC1 (blue box, coordinate ≥ 0.85) and 2 (grey box, coordinate ≥ 0.5) are displayed. Enriched terms (p-value < 0.05) are marked 
with a star. The qualitative group WHO classification is also shown.BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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Single glioma data set: MFA highlights a good separation between glioblastomas and lower grade gliomas Figure 6
Single glioma data set: MFA highlights a good separation between glioblastomas and lower grade gliomas. 
Tumors are presented as points on the scatter plot created with the first two main dimensions of MFA. Each sample (dot) is 
colored following the glioma subtype (WHO classification); mean individual are also displayed (squares). Projection of the 
tumors onto PC1 underlines a separation between glioblastomas (GBM) and lower grade gliomas (oligodendrogliomas, astro-
cytomas, oligoastrocytomas). PC2 differentiates oligo-astrocytomas (OA) from the other subtypes (oligodendrogliomas, astro-
cytomas, GBM). PC1 is linked to characteristics of glioblastoma stating transcriptional differences between grade IV and lower 
grade gliomas. PC2 is related to characteristics of oligodendrogliomas highlighting OA particular signatures.BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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Figure 8 shows the graphical results of our approach
applied to the nutrimouse data set. The individual factor
maps (Figure 8A) separates the mice according to Diet
(PC1) and Genotype (PC2). Mice fed the COC diet are
separated from the other mice on PC1. PPAR  deficient
mice are separated from wild-type mice on PC2. This PC
Table 2: Single data set: Genes strongly correlating with gliobastoma.
Gene Symbol Gene Name PC1
S100A11 S100 calcium binding protein A11 0.895
ANXA2 annexin A2 0.876
CLIC1 chloride intracellular channel 1 0.871
HEXB hexosaminidase B (beta polypeptide) 0.868
MRC2 mannose receptor, C type 2 0.867
FRY furry homolog (Drosophila) -0.834
PHYHIPL phytanoyl-CoA 2-hydroxylase interacting protein-like -0.848
CLASP2 cytoplasmic linker associated protein 2 0.851
GLUD1 glutamate dehydrogenase 1 -0.855
MAPT microtubule-associated protein tau -0.874
The first 10 genes most strongly correlating with PC1 are shown with identifiers and corresponding coordinate. Among these ten genes, four are 
co-cited with 'glioma' on PubMed and five with 'cancer'. And the Ingenuity Pathway Analysis gives links between ANXA2, CLIC1, HEXB, MAPT and 
S100A11 in a network related to 'Cellular Movement, Cell-To-Cell Signaling and Interaction, Nervous System Development and Function'.
Table 3: Single data set: Gene Ontology terms highly associated with gliobastoma
Enrich. GO Identifier Go Term PC1
Cell cycle/Death
* GO:0016265 death 0.953
GO:0007049 cell cycle 0.958
* GO:0008219 cell death 0.956
* GO:0012501 programmed cell death 0.951
GO:0051726 regulation of cell cycle 0.941
* GO:0006915 apoptosis 0.965
GO:0000074 regulation of progression through cell cycle 0.921
* GO:0042981 regulation of apoptosis 0.923
GO:0045786 negative regulation of progression through cell cycle 0.904
GO:0007050 cell cycle arrest 0.912
Proliferative behavior
* GO:0051179 localization 0.986
* GO:0007154 cell communication 0.985
GO:0007155 cell adhesion 0.966
GO:0040011 locomotion 0.952
* GO:0051234 establishment of localization 0.985
GO:0007267 cell-cell signaling 0.954
GO:0007626 locomotory behavior 0.919
* GO:0008283 cell proliferation 0.917
GO:0051641 cellular localization 0.918
* GO:0042127 regulation of cell proliferation 0.916
* GO:0006928 cell motility 0.916
Development
GO:0007275 multicellular organismal development 0.984
GO:0009653 anatomical structure morphogenesis 0.955
* GO:0030154 cell differentiation 0.951
* GO:0048513 organ development 0.942
GO:0007399 nervous system development 0.943
* GO:0000902 cellular morphogenesis 0.926
The annotation are grouped by meaningful categories (Cell Cycle/Death; Invasive behavior and Development) and are ordered by GO depth. PC1 
coordinates for each GO annotation is provided in the third column. These groups of annotations underline the well known characteristics of 
glioblastomas among other gliomas: a rapid progression with parenchyma invasion by isolated tumor cells sustained by cell cycle dysfunctions. It also 
emphasizes the existence of a relation from neurogenesis-related genes to gliobastoma. Enriched terms (p-value < 0.05) are marked with a star.BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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also highlights LIN and FISH diet. Partial (Figure 8B) and
groups representation (Figure 8D) show that this partition
of mice on PC2 is particularly due to FA data. Mice from
both genotype displayed specific accumulations of FA
families that were present in the diet (Figure 8C). Mice fed
the SUN diet had enriched proportion of n-6 FAs, those
fed the LIN and FISH diets are particularly related to n-3
FAs. Mice fed the COC diet preferentially accumulate
mono-unsaturated FAs in their livers. FA C18:2 n-6 is
accumulated in PPAR   deficient mice when compared
with wild-type mice. In a same way, the separation
between PPAR  deficient mice and wild-type mice on PC2
is explained by PPAR   target genes (Peci, Cyp4a10,
Cyp4a14, Acox1, Acaa1b, Hmgcs2, Cpt2) or genes
involved in hepatic detoxification (Cyp3a11). These MFA-
based interpretations are in agreement with the results of
[31].
The superimposition of prior biological knowledge is pre-
sented in Figure 8D. Annotations correlated to PC1 and
PC2 are generally linked to energetic metabolism. Most of
the GO terms strongly associated with PC1 (i.e, those
related to the COC diet) are related to lipid metabolism
and particularly 'fatty acid oxidation' (0.7). It is known
that hepatic FA catabolism is down-regulated with a satu-
rated diet leading to an accumulation of FA in the liver.
This is in accordance with the results discussed by Martin
et al. [31]. The GO terms associated with PC2 are related
to -ose metabolism. They reveal an effect of the diet FA
content on glucose metabolism. The associated genes
Single glioma data set: Superimposing biological knowledge underline genes potentially involved in gliobastoma Figure 7
Single glioma data set: Superimposing biological knowledge underline genes potentially involved in gliobas-
toma. Each group of variables is projected onto the factor map created by MFA: active group or gene expression data set (tri-
angle) and supplementary groups or gene modules (points) are plotted. To facilitate the interpretation of the plot, only GO 
terms representing modules highly linked to the PC1 (blue box, coordinate ≥ 0.95, number of annotated genes <50) and PC2 
(grey box, coordinate ≥ 0.4) are displayed. Enriched terms (p-value < 0.05) are marked with a star.BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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(Ppara, Pklr, Gck, G6pdx, G6pc, Pdk4) also suggest a pos-
sible role of PPAR   in these mechanisms. These gene
expression changes were highlighted in the Table 4 in [31]
but not further discussed. It would however be of great
interest to precise this putative role of FA diet composition
in relation to metabolic syndromes and diabetes.
Conclusion
Our approach based on MFA in the sense of Escofier-Pagès
aims at providing a multivariate data analytic technique
for applications in biological systems. It is dedicated to
combined 'Omics' data structured into groups and its pur-
pose is also particularly to help on their functional inter-
pretations. MFA is firstly used to simultaneously analyze
the structure emerging from the separate analysis of each
molecular levels and to supply principal components
which summarize parts of the data variability. The com-
mon structures are underlined and graphical outputs are
provided such that biological meaning becomes retrieva-
ble. Partial representations allow the visualization of each
'Omics' point of view. The addition of sample annota-
tions as categorical supplementary variables is used to
attach a biological meaning to each component. Func-
tional interpretation is obtained by superimposing bio-
logical knowledge on the experimentally interpreted
plots. Such work is done by building gene modules from
formalized annotations. Modules assembled as sets of
genes are projected as supplementary information onto
the plane spanned by the two principal components
issued from MFA. In this way, we provide a measurement
of the correlation between each module and each compo-
nent. It thus becomes possible to attach functionally
meaningful characteristics to each experimentally inter-
preted component.
With our method, investigation of microarray data is sup-
ported by a step-by-step sequence of graphical representa-
tions. MFA plots provide a clear visualization of the data.
Each plot corresponds to one interpretable entity: Individ-
ual Factor Map, Variables Correlation Circle and Groups
Representation; all of them sharing closely related dimen-
sions. Exploration and functional interpretation are thus
based on the understanding of these dimensions. Moreo-
ver, in our approach, annotations are not transformed but
are used to create GO modules. GO modules are assem-
bled with the expression values of all its constituting
genes. When projecting the corresponding annotation,
this allows the consideration of the transcriptome struc-
ture of a GO module instead of only appreciate GO anno-
tations via boolean vectors.
We have illustrated our approach on a complex setting
which is the study of human brain cancers. Firstly, we
focused on a study combining the genome and the tran-
scriptome of gliomas and secondly, an other study related
only to the transcriptome of these tumors. The latter one
allows us to show that our approach could be applied to
a single group of data (classical microarrays), which is the
most frequently methodology used in the high-througth-
put area of biology. The addition of annotations as sup-
plementary gene modules give very good insights into the
molecular bases of malignant primary brain tumors. Rel-
evant mechanisms involved in cancer were identified, and
more precisely some well defined in glioblastoma (such
as alteration of the cell cycle, proliferative behavior and
development/cell differentiation).
Using the nutrimouse study, we have tried to show the
general applicability of MFA to any investigations needing
a comprehensive view of the data. Futhermore, one major
advantage of this method is not to be bound to any spe-
cific experimental design nor to any type of annotation.
Gene modules can therefore be created with any gene
related knowledge: processes (GO terms from the three
hierarchies, SwissProt keywords), pathways (KEGG, Bio-
Carta, Reactome), structural or promoter informations
(TRANSFAC, TRRD and COMPEL [32]).
Methods
Brain cancer data sets
Three microarray experiments on human glial tumors
were used. We retrieved the corresponding publicly avail-
able data sets as 'Series Matrix Files' (GSE1991, GSE2223
and GSE4412) from the Gene Expression Omnibus
(GEO) database [33]. Bredel et al. studies, noted Multiple
data sets, were performed respectively at the transcriptome
[19] and at the genome level [20] on the same tumor sam-
ples (GSE1991 and GSE2223). The one of Freije et al.,
noted Single data set, was performed at the transcriptome
level only [34] (GSE4412). It is used to illustrate the appli-
cation of our methodology in a single data framework. We
considered the four main types of glial tumors defined by
the standard World Health Organization (WHO) classifi-
cation: O, oligodendrogliomas; A, astrocytomas; OA,
mixed oligo-astrocytomas and GBM, glioblastomas. We
retrieved, for each data set, only the corresponding
hybridization. From an histological point of view, A and
GBM are astrocytic tumors, O are oligodendrocytic
tumors and OA are mixed tumors. According to WHO
grading: GBM are grade IV and O, OA and A are lower
grade gliomas.
Multi-way glioma data set
We retrieved the CGH-array and transcriptome data corre-
sponding respectively to the genetic alterations and the
transcriptomic changes highlighted by Bredel et al. (see
[35] and [36] supplementary data) for 43 tumor samples
(5 A, 8 O, 6 OA, 24 GBM). Measurements were expressed
as ratios of the two channels intensities: tumor DNA over
sex-matching reference DNA for the CGH-array data andBMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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Multi-way nutrimouse data set: MFA approach provides findings in accordance with those found by specialists Figure 8
Multi-way nutrimouse data set: MFA approach provides findings in accordance with those found by specialists. 
A and B. Individual factor maps show partition of the mice according to Diet and Genotype. Mice fed the COC diet (black cir-
cles and triangles) are separated from the other mice on PC1. PPAR  deficient mice (triangles, PPAR) are separated from wild-
type mice (circles, WT) on PC2. C. Variables representation. The genes and FAs most correlated to each principal compo-
nents are named. Mice from both genotype displayed specific accumulations of FA families. Mice fed the SUN diet had enriched 
proportion of n-6 FAs, those fed the LIN and FISH diets are particularly related to n-3 FAs. Mice fed the COC diet preferen-
tially accumulate mono-unsaturated FAs in their livers. Genes most correlated with PC2 are PPAR  target genes (Peci, 
Cyp4a10, Cyp4a14, Acox1, Acaa1b, Hmgcs2, Cpt2) or genes involved in hepatic detoxification (Cyp3a11). D. Enriched GO 
terms (p-value < 0.05) are projected on the Groups scatter-plot, the most correlated to each PC are named. Annotations 
related to PC1 and PC2 are respectively linked to FA and glucose metabolism. The GO term 'cardiac muscle cell differentia-
tion' (GO:0055007) is enriched by class II nuclear receptors (retinoid × receptors and retinoic acid receptors) which are also 
key regulators of lipid metabolism.BMC Genomics 2009, 10:32 http://www.biomedcentral.com/1471-2164/10/32
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tumor RNA over non-neoplastic brain RNA for the tran-
scriptome data. Classical standardization was performed
on the data: ratios of the two channels intensities were log2
tranformed and mean centered per array. Two matrices of
numerical variables were built: K1 contains the data for the
expression study (eX), and K2 those from the genome
investigation (CGH). Each matrix has 43 samples (5A,
8O, 6OA, 24GBM); K1 has 489 genes and K2 has 113
genes.
Single glioma data set
Data files (Affymetrix HG-U133A and HG-U133B) corre-
sponding to 85 tumor samples (8 A, 11 O, 7 OA, 59 GBM)
were selected. Data were prepared as described by [34].
Briefly, intensities were log10 tranformed and median-cen-
tered per array. Probe sets were then filtered to select for a
0.2 coefficient of variation with at least 10% of the sam-
ples having an expression intensity > 500. One way anal-
ysis of variance (ANOVA) was carried out using the
subsequent probe sets and the WHO classification factor
corresponding to each tumor type; significance was set
equal to 10-5. This yielded 615 probe sets, which contain
most of the variation in gene expression information
across all of the samples. The corresponding data matrix,
K3, has 85 samples and 615 genes.
Nutrimouse data set
This data set corresponds to a nutrition study in mouse. A
full description of the experimental settings is provided in
[31] and data are available in the CCA R package [37].
Experimental design has two factors: Genotype and Diet.
Genotype includes wild-type (WT) and PPAR  knock-out
mice (20 and 20). Diet includes 5 levels depending on
their fatty acid (FA) composition: a reference diet (REF), a
saturated FA diet (COC), an  6 FA-rich diet (SUN), an  3
FA-rich diet (LIN) and a corn/colza/enriched fish oils diet
(FISH). Data is composed of two sets of variables: K1 con-
tains the data for the transcriptome study, and K2 those for
hepatic FA measurements by gas chromatography. Each
matrix has 40 samples (mice) (Genotype, 2 levels and
Diet, 5 levels); K1 has 115 genes and K2 has 21 FA.
GO annotations
We converted the array probes ID to suitable identifiers
for all the data sets. Gene symbol were extracted from the
HUGO Gene Nomenclature (HGNC) database [38] using
the array probes description provided by GEO and man-
ual searches. The functional annotations of the corre-
sponding genes were retrieved from the Human subset of
the Gene Ontology Annotation (GOA) database [39]. We
restricted the annotations to focus on the GO biological
process (BP) terms only. We used the true path rule [40] to
associate each gene with all the GO terms subsumed by its
annotated terms. The GO BP terms annotating only one
gene were not taken into account. The enrichment of each
GO term was computed using the NIH-DAVID software
http://david.abcc.ncifcrf.gov/. Fisher Exact statistics were
calculated based on the whole genome (human or
mouse) with corresponding DAVID gene ID as the refer-
ence. GO terms were considered enriched for a modifided
Fisher Exact p-value (EASE score) < 0.05. We assigned a BP
to a set of genes, and built modules by compiling the data
profiles of the genes involved in the same biological proc-
ess. To formalize, in the case of two data tables, let K
denotes the concatenation of the matrices K1 and K2 (or
only K3 in the case of single data set framework), and let
 denotes the restriction of K to the genes associated
with the ith BP. The   have several levels: some are very
large when others are nested and well-focused. For the
Multiple data sets, the 288 BPs (corresponding to eX) were
made from 2 to 324 genes (the mean number of genes in
a biological process is equal to 20.84 and the median is 7)
and 82 BPs (corresponding to CGH) were made from 2 to
66 genes (the mean number of genes in a biological proc-
ess is equal to 9.33 and the median is 4). For the Single
data set, 1081 BPs were made from 2 to 405 genes (the
mean number of genes in a biological process is equal to
14.5 and the median is 4). Data are then divided into four
parts: samples description (WHO), data from expression
microarrays (eX), data from CGH arrays (CGH) (or only
eX in the case of the single data set) and gene annotations
(BP).
Data analysis
Here, we briefly describe MFA and focus on one of its
main features: the possibility to add supplementary
groups of variables. A schematic of our approach is pro-
vided Figure 1. For more information about the mathe-
matical details of MFA, one could read [41].
Application of MFA to 'Omics' data tables
We consider the merged data set: K = [K1, K2,..., KJ], where
each Kj corresponds to an 'Omics' data table. Firstly, sepa-
rate analysis are performed by principal components anal-
ysis (PCA) on each group j of variables. Secondly, a global
analysis is carried out: each variable belonging to a group
j is weighted by 1/ , where   denotes the first eigen-
value of the matrix of variance-covariance associated with
each data table Kj. The rationale of the scaling is that infor-
mation that is common to the data tables emerges.
Besides no data table can, by itself, generate the first
dimension of the global analysis. The first dimension's
K BPi
K BPi
l1
i l1
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variance of each data table is then equal to one. In such
way, MFA provides a balanced representation of each
individual according to the joint data table K, but also a
partial representation of each individual according to each
of the group j of variables. The corresponding graphical
displays (Individual Factor Map and Variables Represen-
tation) are read as for PCA. The partial individual ij is on
the side of the variables of the group j for which it takes
high values, and on the opposite side of the variables of
the group j for which it takes low values. Partial represen-
tations of a same individual are all the more close that
they do express the same information. And, the balanced
representation of an individual i is located in the exact
barycenter of the points {ij, j = 1,..., J}. Each category is
represented by the center of gravity of the cloud of all its
constituting individuals. The representation of the varia-
bles is used to describe the dimensions as in PCA. MFA
provides also a representation of each matrix of variables
(Groups Representation) that allows the visualization of
specific and common structures. Consequently, it is possi-
ble to get an overall picture of the common structure
emerging from the Kj.
Integration of biological knowledge: adding supplementary groups of 
variables
By integrating biological knowledge, we want to identify
the biological processes that best reflect the molecular
changes characterizing the conditions under study. From
a biological point of view, a biological process can be seen
as a module of genes (set of genes with related molecular
data); from a statistical point of view, a biological process
can be seen as a group of variables. We formalized the BP
modules as   matrices containing the restriction of the
whole data set to the genes associated with the BP i. Each
 denotes a matrix of dimension n × pi, where n is the
number of tumors and pi is the number of genes associ-
ated with the BP i. We then used one feature of MFA that
consists in the addition supplementary groups of varia-
bles. These supplementary groups of variables do not par-
ticipate to the construction of the dimensions. This is
essential since a gene belonging to several biological proc-
esses would have more importance in the analysis if the
groups were active. This feature lies as MFA could be seen
as a particular generalized canonical analysis where the
general variables are related to the sets of variables as
strongly as possible in the sense of the Lg measure (instead
of the multiple correlation coefficient R2). The Lg measure
between one numerical variable z and a set of variables
 = {vk, k = 1,..., Kj} is defined by the inertia of all vari-
ables vk projected upon z. If Lg(z, Kj) = 0, the variable z is
not correlated to any variable of the set Kj. Due to the MFA
weighing, 0 ≤ Lg(z, Kj) ≤ 1 and Lg(z, Kj) = 1 when z is the
first principal component of Kj. Let Fs be the dimension of
rank s (coordinates of the individuals) provided by MFA
performed on K. The projection of the   is made by
means of its scalar product matrix between individuals.
This matrix denoted Wi  is a a (I  ×  I) matrix (Wi  =
) and can be considered as an element of the
space  . This element is projected on the dimensions
of   induced by the vectors issued from the matrices
Fs . Given that the coordinates of a group in this repre-
sentation is interpreted as a measure of relationship
related to Lg, the two following properties lie: (i) the coor-
dinates are always comprised between 0 and 1, and (ii) a
small distance between two groups along the principal
component of rank s means that these two groups include
the structure expressed by Fs each one with the same inten-
sity. This representation of the groups is made available by
means of a graphical display of the   as points in a
scatter plot. It has to be read as follow: the coordinate of a
given group is all the more close to 1 than the variables of
this group are highly correlated with the dimension issued
from the MFA (either positively or negatively). Hence, two
groups are all the more close than the structures they
induce on the observations are close.
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